Tumors of the Esophagus and Stomach
SECURE PAYMENT
SHIPMENT
FREE RETURN
Informations
Since the publication of the previous edition of Tumors of the Esophagus and Stomach, great advances in many areas of tumor biology have led to a better understanding of the pathogenesis, pathology, and molecular biology of epithelial and stromal malignancies of the upper gastrointestinal tract. Many of these advances have led to specific improvements in diagnosis, prognosis, treatment, and thus, survival in patients affected by these tumors. This edition of the Fascicle was written to highlight these advances, and more specifically, to help pathologists diagnose diseases more accurately and understand how pathology contributes to clinical treatment in the new age of personalized and targeted therapy.
Notable advances described in this publication include:
- 1) expansion of our understanding of the pathologic features and molecular pathogenesis of carcinomas of the esophagus and stomach, most of which develop through a chronic inflammation-metaplasia-dysplasia-carcinoma sequence. Important refinements in the classification of neoplastic precursor lesions have been made since the last AFIP series, including the morphologic and endoscopic subtypes, and this has led to improvements in surgical treatment with a strong trend toward minimization in the form of endoscopic mucosal and submucosal dissections
- 2) discovery of new diseases, such as gastric adenocarcinoma and proximal polyposis syndrome (GAPPS), a special variant of familial adenomatous polyposis, and significant advances in our knowledge regarding the molecular characterization of genetic polyposis syndromes
- 3) great expansion in the molecular-pathology correlation, morphologic diversity, classification, and therapeutic options of gastrointestinal stromal tumors (GISTs)
- 4) reclassification and refinement of prognostic factors related to neuroendocrine tumors
- 5) improvements in the role of cytology in the diagnosis of tumors of the upper gastrointestinal tract.
This book has been written with the pathologist in mind first by using tables that illustrate salient pathologic, molecular, and differential diagnostic features of key entities that are often difficult to distinguish from each other. Specific color photographs of classic tumors and morphologic variants often difficult to recognize are used throughout.
- Shipping Information
- Files
Description
Since the publication of the previous edition of Tumors of the Esophagus and Stomach, great advances in many areas of tumor biology have led to a better understanding of the pathogenesis, pathology, and molecular biology of epithelial and stromal malignancies of the upper gastrointestinal tract. Many of these advances have led to specific improvements in diagnosis, prognosis, treatment, and thus, survival in patients affected by these tumors. This edition of the Fascicle was written to highlight these advances, and more specifically, to help pathologists diagnose diseases more accurately and understand how pathology contributes to clinical treatment in the new age of personalized and targeted therapy.
Notable advances described in this publication include:
- 1) expansion of our understanding of the pathologic features and molecular pathogenesis of carcinomas of the esophagus and stomach, most of which develop through a chronic inflammation-metaplasia-dysplasia-carcinoma sequence. Important refinements in the classification of neoplastic precursor lesions have been made since the last AFIP series, including the morphologic and endoscopic subtypes, and this has led to improvements in surgical treatment with a strong trend toward minimization in the form of endoscopic mucosal and submucosal dissections
- 2) discovery of new diseases, such as gastric adenocarcinoma and proximal polyposis syndrome (GAPPS), a special variant of familial adenomatous polyposis, and significant advances in our knowledge regarding the molecular characterization of genetic polyposis syndromes
- 3) great expansion in the molecular-pathology correlation, morphologic diversity, classification, and therapeutic options of gastrointestinal stromal tumors (GISTs)
- 4) reclassification and refinement of prognostic factors related to neuroendocrine tumors
- 5) improvements in the role of cytology in the diagnosis of tumors of the upper gastrointestinal tract.
This book has been written with the pathologist in mind first by using tables that illustrate salient pathologic, molecular, and differential diagnostic features of key entities that are often difficult to distinguish from each other. Specific color photographs of classic tumors and morphologic variants often difficult to recognize are used throughout.
test
Shipping Information
Επιστροφές
ΠΟΛΙΤΙΚΗ ΕΠΙΣΤΡΟΦΩΝ
Στόχος μας είναι να εξασφαλίσουμε την απόλυτη ικανοποίησή σας. Αν για οποιονδήποτε λόγω, δεν μείνετε ευχαριστημένοι από την παραγγελία σας, μπορείτε να ασκήσετε το δικαίωμά σας να επιστρέψετε μέρος ή όλα τα προϊόντα που αγοράσατε εντός δεκατεσσάρων (14) ημερών από την ημερομηνία παραλαβής. Αν δεν υπάρχει διαθέσιμο
το ανάλογο προϊόν που επιθυμείτε, το ποσό διαφοράς που προκύπτει διατηρείται στον λογαριασμό σας για να το χρησιμοποιήσετε για μία άλλη αγορά. Θα γίνεται αποδεκτή μόνο η επιστροφή των προϊόντων που βρίσκονται σε άριστη κατάσταση. Παρακαλώ, σημειώστε ότι η αποστολή του μη επιθυμητού προϊόντος γίνεται με εταιρεία courier με χρέωση της εταιρίας μας. Η αποστολή του νέου προϊόντος γίνεται μέσω εταιρεία courier με χρέωση πελάτη.
ΕΛΛΑΤΩΜΑΤΙΚΟ ΠΡΟΙΟΝ
Στην περίπτωση που λάβετε ένα ελαττωματικό ή κατεστραμμένο προϊόν το βιβλιοπωλείο μας θα καταβάλλει κάθε προσπάθεια για να αντικατασταθεί με ένα ίδιο ή παρόμοιο προϊόν χωρίς κάποιο επιπλέον κόστος για σας.
Παρακαλούμε επικοινωνήστε μαζί μας με e-mail στο ipokratis@ipokratis.gr ή στο 2310212212 για περαιτέρω διευκρινήσεις.
